Replies to post #591 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

That makes sense, davidal66. The recent release on VB-600 precedes their move into deeper investigation. Looks like they're following up VB-201 with another (more promising?) atherosclerosis candidate.